362. Paul Coletta, Co-Founder & CEO of Vero Bioscience

Podcast: Fitt Insider · Joe Vennare

Opublikowano: 2026-10-26

Today, I'm joined by Paul Coletta, co-founder & CEO of Vero Bioscience. A predictive health company, Vero uses proteomic blood tests and proprietary AI to measure and improve organ-level aging. In this episode, we discuss building a closed-loop health system powered by proteomics. We also cover: Why organ-level data beats whole-body scores How proteomics differs from other biological age measures Reproducibility, clinical validation, and roadmap to launch Subscribe to the podcast → insider.fitt.co/podcast Subscribe to our newsletter → insider.fitt.co/subscrib...